Home
About
Overview
Sharing Data
ORCID
Help
History (59)
Tyrosine kinase mutations in human cancer.
Localized hand-foot syndrome after intra-arterial hepatic chemotherapy with floxuridine: a clinical case.
Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans.
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice.
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.
See All 59 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy. Mol Cancer. 2014 Oct 24; 13:242.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Neutralizing
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Cell Line, Tumor
Cell Proliferation
Cetuximab
Drug Resistance, Neoplasm
ErbB Receptors
Humans
Lung Neoplasms
Male
Mice
Mice, Nude
Phosphatidylinositol 3-Kinases
Proto-Oncogene Proteins c-akt
Receptor, ErbB-2
Receptor, ErbB-3
Signal Transduction
Xenograft Model Antitumor Assays
authors with profiles
Ravi Salgia